Conference
Platelet inhibition with the glycoprotein IIb/IIIa receptor antagonist Lamifiban in high risk patient subsets: Studies to determine the correlation between platelet-mediated prothrombotic activity and clinical risk
Authors
Becker RC; Ali O; Harrington RA; Ball SP; Spencer FA; Gore JM
Volume
96
Pagination
pp. 4196-4196
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
October 21, 1997
Conference proceedings
CIRCULATION
Issue
8
ISSN
0009-7322